MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-26-2026
Perrigo Company plc P/E Ratio 2011-2026 | PRGO
Annual P/E Ratio Perrigo Company plc
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.38 | -23 | -291 | -36.1 | -67.9 | -32.8 | 53.9 | 48.5 | 107 | -2.66 | 211 | 86.6 | 25.1 | 26.7 | 24 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 211 | -291 | 8.57 |
P/E Ratio of other stocks in the Drug manufacturers industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aurora Cannabis
ACB
|
-1.32 | $ 3.51 | 1.59 % | $ 86.3 M |  Canada |
 |
Alimera Sciences
ALIM
|
-5.04 | - | - | $ 142 M |  USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
-0.679 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
-4.35 | - | - | $ 754 M | USA |
 |
AcelRx Pharmaceuticals
ACRX
|
-1.71 | - | 7.5 % | $ 6.35 M | USA |
 |
Cronos Group
CRON
|
-49.6 | $ 2.53 | -0.48 % | $ 1.31 B | Canada |
 |
Canopy Growth Corporation
CGC
|
-0.237 | $ 1.05 | 2.94 % | $ 113 M | Canada |
 |
Agile Therapeutics
AGRX
|
-0.0895 | - | 10.11 % | $ 58.2 M | USA |
 |
Assertio Holdings
ASRT
|
-2.48 | $ 12.3 | 4.5 % | $ 78.8 M | USA |
 |
DURECT Corporation
DRRX
|
-1.15 | - | - | $ 50.1 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
-14.7 | - | - | $ 2.06 B |  France |
 |
Eagle Pharmaceuticals
EGRX
|
9.54 | - | -39.89 % | $ 27.7 M | USA |
 |
Evolus
EOLS
|
-5.26 | $ 4.84 | -3.97 % | $ 312 M | USA |
 |
Evoke Pharma
EVOK
|
-0.287 | - | - | $ 36.6 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-1.9 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
-0.775 | - | 2.45 % | $ 38.1 M | Canada |
 |
Catalent
CTLT
|
-10.4 | - | - | $ 11.5 B | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
-46.5 | $ 3.01 | -1.63 % | $ 42.3 M | USA |
 |
Jupiter Wellness
JUPW
|
-1.67 | - | - | $ 33.6 M | USA |
 |
Athenex
ATNX
|
-0.111 | - | -23.39 % | $ 1.76 M | USA |
 |
Endo International plc
ENDP
|
-0.0278 | - | - | $ 28.9 M |  Irlanda |
 |
Harrow Health
HROW
|
-376 | $ 34.99 | 0.23 % | $ 1.29 B | USA |
 |
Organogenesis Holdings
ORGO
|
482 | $ 2.56 | -0.97 % | $ 337 M | USA |
 |
Pacira BioSciences
PCRX
|
-11.8 | $ 21.71 | -4.32 % | $ 1 B | USA |
 |
Emergent BioSolutions
EBS
|
-0.182 | $ 8.14 | -2.28 % | $ 417 M | USA |
 |
OrganiGram Holdings
OGI
|
-2.92 | $ 1.44 | 1.27 % | $ 402 M | Canada |
 |
Sundial Growers
SNDL
|
-0.00386 | $ 1.45 | 0.35 % | $ 3.37 M | Canada |
 |
China Pharma Holdings
CPHI
|
-0.959 | $ 0.61 | -2.26 % | $ 10.7 M |  China |
 |
Veru
VERU
|
-2.85 | $ 2.43 | 2.53 % | $ 328 M | USA |
 |
ProPhase Labs
PRPH
|
7.07 | - | - | $ 5.07 M | USA |
 |
TherapeuticsMD
TXMD
|
-2.33 | $ 2.3 | 5.99 % | $ 24 M | USA |
 |
Lannett Company
LCI
|
-0.108 | - | 1.15 % | $ 7.11 M | USA |
 |
Radius Health
RDUS
|
-5.38 | - | - | $ 1.42 B | USA |
 |
Viatris
VTRS
|
336 | $ 13.81 | 2.22 % | $ 16.6 B | USA |
 |
Neoleukin Therapeutics
NLTX
|
0.126 | - | - | $ 193 M | Canada |
 |
Sonoma Pharmaceuticals
SNOA
|
-1.06 | $ 2.5 | 3.73 % | $ 3.1 M | USA |
 |
Relmada Therapeutics
RLMD
|
-1.64 | $ 6.31 | 2.1 % | $ 190 M | USA |
 |
Rockwell Medical
RMTI
|
-4.2 | $ 1.04 | 8.87 % | $ 24.3 M | USA |
 |
PetIQ
PETQ
|
186 | - | 1.64 % | $ 400 M | USA |
 |
OptiNose
OPTN
|
-5.4 | - | - | $ 1.08 B | USA |
 |
PLx Pharma
PLXP
|
-2.56 | - | -27.8 % | $ 2.56 M | USA |
 |
SCYNEXIS
SCYX
|
-4.41 | $ 0.91 | 1.46 % | $ 45.4 M | USA |
 |
Recro Pharma
REPH
|
-10 | - | -4.76 % | $ 65.3 M | USA |
 |
Solid Biosciences
SLDB
|
-1.81 | $ 7.77 | 3.81 % | $ 317 M | USA |
 |
Tilray
TLRY
|
-0.821 | $ 6.94 | 0.58 % | $ 4.29 B | Canada |
 |
Tricida
TCDA
|
-2.03 | - | - | $ 3.25 M | USA |
 |
cbdMD
YCBD
|
-11 | $ 0.74 | 2.91 % | $ 3.19 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
-0.536 | - | - | $ 55.5 M | USA |
 |
Zomedica Corp.
ZOM
|
-3.97 | - | -0.21 % | $ 98 M | USA |